Thursday, September 26, 2013

Immune Design Names Business Head

Seattle-based Immune Design said Thursday that it has named Stephen R. Brady as its Chief Business Officer. Brady was most recently CFO at 3-V Biosciences, and also has served at Proteolix, Lexicon Pharmaceuticals, Lazard Venture Advisors, and Morrison & Foerster LLP. Immune Design said BRady will lead the company's business functions, including strategic planning and corporate development activities. Immune Design is creating new vaccines for infectious diseases, and is venture backed by Alta Partners, Proquest Investments, The Column Group, and Versant Ventures.